| |
|
|
| Name: |
Casdin Capital LLC |
| City: |
New York |
| State: |
NY |
| Zip: |
10019 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
39 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
RVMD |
Revolution Medicines, Inc. |
1 |
- |
$39.77 |
$181,055,000 |
5,617,599 |
13.47% |
17,155,000 |
-97,176 |
3.429 |
N/A |
|
|
FLDM |
Fluidigm Corp |
2 |
- |
$2.59 |
$167,770,000 |
61,907,605 |
12.48% |
165,118,000 |
60,707,605 |
83.524 |
Scientific & Technica... |
|
|
BLFS |
Biolife Solutions Inc |
3 |
- |
$21.88 |
$161,518,000 |
8,707,165 |
12.02% |
20,027,000 |
0 |
18.407 |
Biotechnology |
|
|
SRPT |
Sarepta Therapeutics Inc |
4 |
- |
$128.30 |
$138,393,000 |
1,069,000 |
10.3% |
41,336,000 |
62,500 |
1.27 |
Drug Manufacturers - ... |
|
|
RLAY |
Relay Therapeutics, Inc. |
5 |
- |
$7.53 |
$61,616,000 |
7,423,574 |
4.59% |
-19,725,000 |
35,631 |
5.484 |
N/A |
|
|
ALNY |
Alnylam Pharmaceuticals Inc |
6 |
- |
$150.90 |
$53,503,000 |
358,000 |
3.98% |
16,178,000 |
163,000 |
0.291 |
Biotechnology |
|
|
RNA |
Avidity Biosciences, Inc. |
7 |
- |
$29.62 |
$53,205,000 |
2,084,841 |
3.96% |
42,564,000 |
909,091 |
2.622 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
8 |
- |
$25.97 |
$51,581,000 |
1,875,000 |
3.84% |
7,370,000 |
425,000 |
2.094 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
9 |
- |
$36.38 |
$47,869,000 |
1,116,867 |
3.56% |
3,365,000 |
25,000 |
2.408 |
N/A |
|
|
EXAS |
Exact Sciences Corp |
10 |
- |
$53.49 |
$44,889,000 |
650,000 |
3.34% |
13,817,000 |
230,000 |
0.366 |
Biotechnology |
|
|
VERV |
Verve Therapeutics, Inc. |
11 |
- |
$0.00 |
$40,625,000 |
3,059,094 |
3.02% |
-1,322,000 |
50,000 |
3.804 |
N/A |
|
|
TNYA |
Tenaya Therapeutics, Inc. |
12 |
- |
$0.00 |
$35,213,000 |
6,732,971 |
2.62% |
14,537,000 |
351,594 |
10.522 |
N/A |
|
|
ILMN |
Illumina Inc |
13 |
- |
$107.39 |
$34,055,000 |
248,000 |
2.53% |
-9,527,000 |
-65,000 |
0.17 |
Scientific & Technica... |
|
|
BPMC |
Blueprint Medicines Corp |
14 |
- |
$102.71 |
$30,960,000 |
326,378 |
2.3% |
855,000 |
0 |
0.494 |
N/A |
|
|
WGS |
GeneDx Holdings Corp |
15 |
- |
$19.99 |
$28,635,000 |
3,136,411 |
2.13% |
20,122,000 |
40,900 |
12.256 |
N/A |
|
|
NGNE |
Neurogene |
16 |
- |
$3.68 |
$26,703,000 |
524,616 |
1.99% |
16,536,000 |
0 |
1.252 |
N/A |
|
|
DNLI |
Denali Therapeutics Inc. |
17 |
- |
$20.06 |
$26,676,000 |
1,300,000 |
1.99% |
-1,222,000 |
0 |
1.084 |
N/A |
|
|
FDMT |
4d Molecular Therapeutics Inc. |
18 |
- |
$0.00 |
$25,488,000 |
800,000 |
1.9% |
4,543,000 |
-233,811 |
1.621 |
N/A |
|
|
BEAM |
Beam Therapeutics Inc. |
19 |
- |
$24.88 |
$22,302,000 |
675,000 |
1.66% |
7,930,000 |
147,000 |
0.828 |
N/A |
|
|
VCYT |
Veracyte, Inc. |
20 |
New |
$21.62 |
$19,011,000 |
857,904 |
1.41% |
19,011,000 |
857,904 |
1.036 |
Biotechnology |
|
|
PLRX |
Pliant Therapeutics, Inc. |
21 |
- |
$0.00 |
$14,900,000 |
1,000,000 |
1.11% |
-13,661,000 |
-577,108 |
1.59 |
N/A |
|
|
IPSC |
Century Therapeutics, Inc. |
22 |
- |
$0.00 |
$13,403,000 |
3,206,380 |
1% |
2,758,000 |
0 |
5.849 |
N/A |
|
|
TSVT |
2seventy Bio, Inc. |
23 |
- |
$0.00 |
$10,700,000 |
2,000,000 |
0.8% |
5,650,000 |
817,377 |
3.849 |
N/A |
|
|
ABCL |
Abcellera Biologics Inc. |
24 |
- |
$0.00 |
$10,691,000 |
2,360,129 |
0.8% |
-2,785,000 |
0 |
0.877 |
N/A |
|
|
TNGX |
Tango Therapeutics Ord Shs |
25 |
- |
$0.00 |
$9,435,000 |
1,188,349 |
0.7% |
-2,330,000 |
0 |
1.165 |
N/A |
|
|
CDXS |
Codexis Inc |
26 |
- |
$3.47 |
$6,980,000 |
2,000,000 |
0.52% |
880,000 |
0 |
3.083 |
Biotechnology |
|
|
ABSI |
Absci Corp |
27 |
- |
$4.61 |
$5,528,000 |
973,260 |
0.41% |
1,440,000 |
0 |
1.058 |
N/A |
|
|
PACB |
Pacific Biosciences Of Cali... |
28 |
- |
$1.85 |
$3,884,000 |
1,035,859 |
0.29% |
-6,278,000 |
0 |
0.345 |
Biotechnology |
|
|
KYTX |
Kyverna Therapeutics |
29 |
New |
$13.33 |
$3,726,000 |
150,000 |
0.28% |
3,726,000 |
150,000 |
0.349 |
N/A |
|
|
GLUE |
Monte Rosa Therapeutics, Inc. |
30 |
- |
$0.00 |
$3,602,000 |
510,882 |
0.27% |
716,000 |
0 |
1.148 |
N/A |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
31 |
- |
$20.76 |
$3,570,000 |
150,000 |
0.27% |
328,000 |
0 |
0.16 |
N/A |
|
|
PRME |
Prime Medicine, Inc. |
32 |
- |
$7.45 |
$2,570,000 |
367,175 |
0.19% |
-683,000 |
0 |
0.378 |
N/A |
|
|
DNA |
Ginkgo Bioworks Holdings, Inc |
33 |
New |
$0.70 |
$1,693,000 |
1,459,747 |
0.13% |
1,693,000 |
1,459,747 |
0.11 |
N/A |
|
|
EXAI |
Exscientia Adr |
34 |
- |
$0.00 |
$1,224,000 |
213,900 |
0.09% |
-147,000 |
0 |
0.178 |
N/A |
|
|
OMIC |
Singular Genomics Systems, ... |
35 |
- |
$0.00 |
$681,000 |
1,323,885 |
0.05% |
72,000 |
0 |
1.85 |
N/A |
|
|
KRON |
Kronos Bio, Inc. |
36 |
- |
$0.00 |
$161,000 |
123,839 |
0.01% |
6,000 |
0 |
0.221 |
N/A |
|
|
FATE |
Fate Therapeutics Inc |
39 |
Closed |
$3.65 |
$0 |
0 |
0% |
-7,667,000 |
-2,050,000 |
0 |
Biotechnology |
|
|
SLGC |
Cm Life Sciences Ii Inc. |
38 |
Closed |
$2.10 |
$0 |
0 |
0% |
-31,889,000 |
-12,604,275 |
0 |
N/A |
|
|
LIAN |
Lianbio |
37 |
Closed |
$0.00 |
$0 |
0 |
0% |
-923,000 |
-206,415 |
0 |
N/A |
|
